Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
OMG! Monday 29th March
Wednesday Tip
Our Wednesday Tip on the 24th March was a Kromek (LSE: KMK) at 15.75p. Amongst other things it has a bio-security automatic system which is (re) designed to detect Covid in the atmosphere in areas of high footfall such as hospitals, retail outlets and airports. The part patented system is on trials and can detect the Covid virus in the air in real time at max rate of 3x per hour. If the Covid in the air is above the ‘safe rate’ action can be taken to reduce the potential threat of spreading. If this prevents further lockdowns, then it would be hard to dispute its value. Recently £13m was raised at 15p and the shares are well funded to achieve success. Buy
Results Previews
Proteome (Aim: Prm) Friday’s second Trading up-date for the year-end to December 2020, stated that profits to be reported are to be materially higher when Finals are reported on Thursday. This is primarily due to higher-than-expected royalty receipts from Thermo Scientific for the last quarter of 2020. The is a substantial order book as delayed business is carried forward and traction from its key partnerships is building. Now its profitable further funding would only be needed for scaling production to meet orders. Buy
Itaconix (LSE: ITX) 6.15p reports finals on Tuesday losses are decreasing as it commercializes its sustainable plant-based polymers which are essential ingredients to help differentiate everyday consumer products. The marketing and sales teams have been expanded along and a new vice president of operations appointed. ITX report increasing enquiries about its polymers from major Brands seeking to improve product performance and bolster the sustainability credentials. ITX polymers have been used in a few major new brand launches and reformulations of existing brands in dishwashing detergents, hair styling products, and deodorizing cleaners. In July 2020£1.8m was raised at 1.1p and there is likely to be a further fund raise to achieve profitability. Watching brief
Reviews Section 21st March
EMR – 49.5p – Recovering gently
DEST – 154.5p – Study results by end of March
BOKU – 174p – Identity improving
EYE – 467p – Generating cash
OPTI – 53p – Expanding product range
SBTX – 52p – Share price rises despite Optibiotix sale
KWS – 2374p – Australian purchase
JSG – 153.2p – Ready for recovery
TSG – 118p – Cash bid
SUR – 68.5p – Chairman steps down
HDD – 26p – Recovery in demand later this year
GHS – 1400p – Increased Universe stake
LSAI – 0.43p – Strategic review continues
Finally ……….. markets are paused as while key economic figures are improving its from a low base and it seems too early to get too excited about recovery.
OMG! Opportunity for Massive Gains is a Premium Newsletter on ADVFN with two reports each week.
